Genetic Screen in a Pre-Clinical Model of High-Grade Complex Karyotype Sarcoma Characterizes Drivers of Distinct Sarcoma Subtypes and Identifies New Therapeutic Vulnerabilities

No abstract is available for this paper.

• Publication year

  2023

• Venue

  bioRxiv

• Publication date

  2023-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/2022.06.13.495815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges

  2022cited by this paper
• Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma

  2022cited by this paper
• Cancer statistics, 2022

  2022cited by this paper
• RETRACTED ARTICLE: PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas

  2021cited by this paper
• Mapping genomic and epigenomic evolution in cancer ecosystems

  2021cited by this paper
• Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions

  2020cited by this paper
• The epigenomics of sarcoma

  2020cited by this paper
• TP53 in bone and soft tissue sarcomas.

  2019cited by this paper
• A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

  2019cited by this paper
• Context is everything: aneuploidy in cancer

  2019cited by this paper
• Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development

  2019cited by this paper
• Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.

  2019cited by this paper
• Shortening the Half-Life of Cas9 Maintains Its Gene Editing Ability and Reduces Neuronal Toxicity

  2018cited by this paper
• Role of Activator Protein‐1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells

  2018influential reference
• Abstract A113: Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures

  2018cited by this paper
• Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma

  2018cited by this paper
• Toil enables reproducible, open source, big biomedical data analyses

  2017cited by this paper
• Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.

  2017influential reference
• YAP/TAZ at the Roots of Cancer.

  2016cited by this paper
• Generation of Osteosarcomas From a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.

  2016cited by this paper
• CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing

  2016cited by this paper
• Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains

  2015cited by this paper
• A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas

  2015cited by this paper
• The emerging roles of YAP and TAZ in cancer

  2015cited by this paper
• Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis

  2015cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• The new frontier of genome engineering with CRISPR-Cas9

  2014cited by this paper
• Genetic Screens in Human Cells Using the CRISPR-Cas9 System

  2013influential reference
• WHO classification of tumours of soft tissue and bone

  2013cited by this paper
• Effects on Proliferation and Differentiation of Multipotent Bone Marrow Stromal Cells Engineered to Express Growth Factors for Combined Cell and Gene Therapy

  2011cited by this paper
• Modeling sarcomagenesis using multipotent mesenchymal stem cells

  2011influential reference
• Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.

  2010cited by this paper
• Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy

  2010cited by this paper
• Rank–rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures

  2010cited by this paper
• Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation.

  2010cited by this paper
• Genetically transforming human mesenchymal stem cells to sarcomas

  2009cited by this paper
• Telomerase Immortalized Human Amnion- and Adipose-Derived Mesenchymal Stem Cells: Maintenance of Differentiation and Immunomodulatory Characteristics

  2009cited by this paper
• Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice.

  2009cited by this paper
• JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas.

  2007cited by this paper
• In vitro transformation of mesenchymal stem cells by oncogenic H-rasVal12.

  2007cited by this paper
• Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production

  2007cited by this paper
• A spatially and temporally restricted mouse model of soft tissue sarcoma

  2007cited by this paper
• Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.

  2007cited by this paper
• Production and purification of lentiviral vectors

  2006cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Adult human mesenchymal stem cell as a target for neoplastic transformation

  2004cited by this paper
• Mechanisms of sarcoma development

  2003cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes.

  1999cited by this paper
• Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

  1999cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper

• No citing papers are available for this paper.